Naples
Italy
University of Naples Federico II
STEMI, primary PCI, Cangrelor, pharmacodynamics assessment, platelet inhibition, ticagrelor pretreatment
STEMI, Ranolazine, Multivessel Disease, IMR, AngioIMR, Coronary Microvascular Dysfunction